throbber
1
`2
`3
`4
`5
`6
`7
`8
`9
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`
`Page 1
` UNITED STATES PATENT AND TRADEMARK OFFICE
` BEFORE THE PATENT TRIAL AND APPEAL BOARD
` LUPIN LIMITED,
` Petitioner,
` vs. Case IPR2015-01030
` JANSSEN SCIENCES IRELAND Patent 8,518,987 B2
` UC,
` Patent Owner.
` ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
` CONFIDENTIAL
`
` DEPOSITION OF
` GIRIJ PAL SINGH, Ph.D.
`
` September 4, 2015
` 8:30(cid:160)a.m.
` 6 West Hubbard, Suite 500,
` Chicago, Illinois
`
` Deanna Amore, CSR, RPR, 084-003999
`
`212-267-6868
`
`Veritext Legal Solutions
`www.veritext.com
`
`516-608-2400
`
`PROTECTIVE ORDER MATERIAL
`
`Janssen Ex. 2051
`Lupin Ltd. v. Janssen Sciences Ireland UC
`IPR2015-01030
`(Page 1 of 74)
`
`

`
`Page 2
`
` APPEARANCES OF COUNSEL
`On Behalf of the Petitioner, LUPIN LIMITED:
` RAKOCZY, MOLINO, MAZZOCHI, SIWIK
` MS. DEANNE M. MAZZOCHI
` MR. MATTHEW V ANDERSON
` 6 West Hubbard
` Suite 500
` Chicago, Illinois 60610
` (312) 222-6305
` dmazzochi@rmmslegal.com
` manderson@rmmslegal.com
`On Behalf of the Patent Holder, JANSSEN SCIENCES
`IRELAND UC:
` AKIN GUMP STRAUSS HAUER & FELD
` MR. RUBEN H. MUNOZ
` MS. BARBARA MULLIN
` Two Commerce Street
` 2001 Market Street
` Suite 4100
` Philadelphia, Pennsylvania 19103-7013
` (215) 965-1200
` rmunoz@akingump.com
` bmullin@akingump.com
` - and -
` PATTERSON BELKNAP WEBB & TYLER
` MR. JASON S. GOULD
` 1133 Avenue of the Americas
` New York, New York 10036
` (212) 336-2000
` jgould@pbwt.com
`
` * * * * *
`
`1
`2
`3
`4
`5
`6
`7
`
`89
`
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`
`212-267-6868
`
`Veritext Legal Solutions
`www.veritext.com
`
`516-608-2400
`
`PROTECTIVE ORDER MATERIAL
`
`Janssen Ex. 2051
`Lupin Ltd. v. Janssen Sciences Ireland UC
`IPR2015-01030
`(Page 2 of 74)
`
`

`
`Page 3
`
` I N D E X
`WITNESS EXAMINATION
`GIRIJ PAL SINGH
` EXAMINATION BY MR. MUNOZ 5
` EXAMINATION BY MS. MAZZOCHI 59
` FURTHER EXAMINATION BY MR. MUNOZ 61
` FURTHER EXAMINATION BY MS. MAZZOCHI 61
` EXHIBITS
` NUMBER DESCRIPTION PAGE
` Exhibit 2048 Affidavit of Rachita 18
` Naidu
` Exhibit 2049 1.9.2015 Affidavit of 24
` Shirish Vishnupurikar
` Exhibit 2050 Power of Attorney of 52
` Sophia Mumtaz
`
`EXHIBITS PREVIOUSLY MARKED PAGE FIRST REFERRED TO
` Exhibit 1093 6
`
`1
`2
`3
`4
`5
`6
`7
`8
`9
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`
`212-267-6868
`
`Veritext Legal Solutions
`www.veritext.com
`
`516-608-2400
`
`PROTECTIVE ORDER MATERIAL
`
`Janssen Ex. 2051
`Lupin Ltd. v. Janssen Sciences Ireland UC
`IPR2015-01030
`(Page 3 of 74)
`
`

`
`Page 4
` (Whereupon, the witness was
` duly sworn.)
` MR. MUNOZ: We'll do introductions.
` I'm Ruben Munoz from Akin Gump on behalf of
`Janssen.
` With me is Barbara Mullin from Akin Gump and
`Jason Gould from Patterson Belknap.
` MS. MAZZOCHI: Good morning. My name is Deanne
`Mazzochi of the Rakoczy Molino Mazzochi Siwik law
`firm, and also with me is Matthew Anderson on
`behalf of Lupin Limited.
` MR. MUNOZ: Good morning, Dr. Singh.
` THE WITNESS: Good morning.
` MR. MUNOZ: Could you please state your full
`name.
` THE WITNESS: Can you repeat the question?
` MR. MUNOZ: Could you please state your full
`name.
` THE WITNESS: Girij Pal Singh.
`
`1
`2
`3
`4
`5
`6
`7
`8
`9
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`
`212-267-6868
`
`Veritext Legal Solutions
`www.veritext.com
`
`516-608-2400
`
`PROTECTIVE ORDER MATERIAL
`
`Janssen Ex. 2051
`Lupin Ltd. v. Janssen Sciences Ireland UC
`IPR2015-01030
`(Page 4 of 74)
`
`

`
`Page 5
`
`1
`2
`3
`4
`5
`6
`
` GIRIJ PAL SINGH,
`called as a witness herein, having been first duly
`sworn, was examined and testified as follows:
` EXAMINATION
`BY MR. MUNOZ:
` Q. And what's your address, Dr. Singh?
`
`11
`12
`13
`14
`
` Q. And who is your employer, Dr. Singh?
` A. Lupin Limited.
` Q. Do you have an employment agreement with
`Lupin Limited?
`
`25
`
` MS. MAZZOCHI: Object to form.
`
`212-267-6868
`
`Veritext Legal Solutions
`www.veritext.com
`
`516-608-2400
`
`PROTECTIVE ORDER MATERIAL
`
`Janssen Ex. 2051
`Lupin Ltd. v. Janssen Sciences Ireland UC
`IPR2015-01030
`(Page 5 of 74)
`
`

`
`Page 6
`
`2
`3
`4
`5
`6
`7
`
`9
`10
`11
`12
`13
`
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`
`BY MR. MUNOZ:
` Q. And what entity pays your salary,
`Dr. Singh?
` A. Can you repeat?
` Q. Sure.
` Which company or entity pays your salary?
`
` Q. Do you get pay stubs?
` A. I get salary slip.
` Q. Is that a paper form?
` A. It's a paper form.
` Q. What entity name appears on that pay stub?
`
` Q. Any other entity name?
` A. No.
` Q. I have copies of Exhibit 1093, which is
`your declaration. So we are going to use this
`right now.
` Dr. Singh, I've handed you what has been
`marked already as Exhibit 1093; do you see that?
` A. Yes.
` Q. And do you recognize this document as your
`declaration?
` A. Yes.
`
`212-267-6868
`
`Veritext Legal Solutions
`www.veritext.com
`
`516-608-2400
`
`PROTECTIVE ORDER MATERIAL
`
`Janssen Ex. 2051
`Lupin Ltd. v. Janssen Sciences Ireland UC
`IPR2015-01030
`(Page 6 of 74)
`
`

`
`Page 7
` Q. And if you could please turn to page 5.
` It's actually, page 5. I'm sorry. It's
`actually the last page. We are going to go by the
`page numbers here. The label says page 6 of 6, but
`the original number is page 5.
` Do you see your signature on that page?
` A. Yes.
` Q. Did you sign this declaration on or about
`August 28, 2015?
` A. Yes.
` Q. And did you believe all the statements in
`this declaration to be true when you signed this
`declaration?
` A. Yes.
` Q. And do you still believe that those
`statements are true today?
` A. Sorry?
` Q. Sure.
` Do you still believe that all those
`statements are true?
` A. Yes.
` Q. Are there any mistakes in here that you
`would like to correct?
` A. I don't think so.
` Q. Okay. And who prepared this declaration,
`
`1
`2
`3
`4
`5
`6
`7
`8
`9
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`
`212-267-6868
`
`Veritext Legal Solutions
`www.veritext.com
`
`516-608-2400
`
`PROTECTIVE ORDER MATERIAL
`
`Janssen Ex. 2051
`Lupin Ltd. v. Janssen Sciences Ireland UC
`IPR2015-01030
`(Page 7 of 74)
`
`

`
`Page 8
`
`Dr. Singh?
` MS. MAZZOCHI: Object to form.
` THE WITNESS: Well, this was prepared by
`Rachita Naidu and Shirish.
`BY MR. MUNOZ:
` Q. And just to clarify, Dr. Singh, you said
`that Rachita Naidu and Shirish Vishnupurikar
`prepared this declaration; is that right?
` A. Yes.
` Q. And they prepared it, and you signed it;
`is that correct?
` A. Yes.
` Q. Was there anybody else involved in the
`preparation of this declaration?
` A. I don't think so.
` Q. Did you speak to anyone regarding the
`preparation of this declaration?
` MS. MAZZOCHI: You may answer, but you should
`exclude from your answer any attorneys.
` THE WITNESS: While I'm in India, I spoke to
`Rachita and Shirish.
`BY MR. MUNOZ:
` Q. Anybody else?
` A. And I came here yesterday and discussed
`with Deanne and Matt.
`
`1
`2
`3
`4
`5
`6
`7
`8
`9
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`
`212-267-6868
`
`Veritext Legal Solutions
`www.veritext.com
`
`516-608-2400
`
`PROTECTIVE ORDER MATERIAL
`
`Janssen Ex. 2051
`Lupin Ltd. v. Janssen Sciences Ireland UC
`IPR2015-01030
`(Page 8 of 74)
`
`

`
`Page 9
` Q. And before coming here yesterday, did you
`discuss this declaration with anybody else?
` A. No.
` Q. Dr. Singh, there is a couple of things --
`statements in here that I would like to use for us
`to simply fire a discussion. One of them appears
`at paragraph 4. If you could turn to paragraph 4.
` And it's actually at the top of page 2 of
`the original document, still in paragraph 4.
` You see where it says "Patent
`No. 8,518,987 B2, and then in parenthesis, it says
`the "'987 Patent"; do you see that?
` A. Yes.
` Q. If I refer to the '987 patent in short
`form, will you understand it to mean
`U.S. Patent 8,518,987?
` A. Yes.
` Q. And there is another term here that I
`would like to use. It's in paragraph 7, bottom of
`that same page 2.
` A. Yes.
` Q. You refer to the inter partes review of
`the '987 patent as the instant petition; do you see
`that?
` A. Yes.
`
`1
`2
`3
`4
`5
`6
`7
`8
`9
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`
`212-267-6868
`
`Veritext Legal Solutions
`www.veritext.com
`
`516-608-2400
`
`PROTECTIVE ORDER MATERIAL
`
`Janssen Ex. 2051
`Lupin Ltd. v. Janssen Sciences Ireland UC
`IPR2015-01030
`(Page 9 of 74)
`
`

`
`Page 10
` Q. And I would like to use that short form as
`well. When I say "instant petition," would you
`understand I'm referring to the inter partes review
`of the '987 patent?
` A. Yes.
` Q. Thank you.
` Dr. Singh, you said that Ms. Naidu and
`Mr. Vishnupurikar prepared this declaration; is
`that right?
` A. Yes.
` Q. Did you, yourself, have any personal
`knowledge regarding the content of this
`declaration?
` MS. MAZZOCHI: Object to form.
` THE WITNESS: Yeah, before signing, I have gone
`through this.
`BY MR. MUNOZ:
` Q. But before it was prepared by Ms. Naidu
`and Mr. Vishnupurikar, did you have any personal
`knowledge regarding the content of this
`declaration?
` MS. MAZZOCHI: Object to form.
` THE WITNESS: They discussed with me once they
`are preparing the declaration, and I need to sign.
`
`1
`2
`3
`4
`5
`6
`7
`8
`9
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`
`212-267-6868
`
`Veritext Legal Solutions
`www.veritext.com
`
`516-608-2400
`
`PROTECTIVE ORDER MATERIAL
`
`Janssen Ex. 2051
`Lupin Ltd. v. Janssen Sciences Ireland UC
`IPR2015-01030
`(Page 10 of 74)
`
`

`
`1
`2
`3
`4
`5
`6
`
`11
`12
`13
`14
`15
`16
`17
`18
`
`22
`
`24
`
`Page 11
`
`BY MR. MUNOZ:
` Q. If we turn to paragraph 1, Dr. Singh, it
`says in here that you're the senior vice president
`of research and development and generic research
`for Lupin Limited; do you see that?
` A. Yes.
`
` Q. How many employees within that
`organization?
` MS. MAZZOCHI: Object to form.
` THE WITNESS: You are asking for the generic
`research?
`BY MR. MUNOZ:
` Q. That's correct. Let me clarify the
`question so it's clear.
`
` MS. MAZZOCHI: Object to form.
`
`BY MR. MUNOZ:
`
`212-267-6868
`
`Veritext Legal Solutions
`www.veritext.com
`
`516-608-2400
`
`PROTECTIVE ORDER MATERIAL
`
`Janssen Ex. 2051
`Lupin Ltd. v. Janssen Sciences Ireland UC
`IPR2015-01030
`(Page 11 of 74)
`
`

`
`Page 12
`
` Q. Sure.
` And is it fair to say you are the head of
`that organization?
` A. Yes.
`
` Q. Do they report to you?
`
` Q. Who is that person in between?
`
` Q. Can you spell that, please.
`
` involved in the
` Q. And was
`preparation of the declaration?
` A. No.
` Q. And, Dr. Singh, just to close the loop on
`the organizational structure, who do you report to?
`
` Q. And what is -- is that a him or her?
` A. Him.
` Q. What is his position in the organization?
`
`2
`3
`4
`5
`
`9
`
`12
`
`14
`
`16
`17
`18
`19
`20
`
`22
`23
`24
`
`212-267-6868
`
`Veritext Legal Solutions
`www.veritext.com
`
`516-608-2400
`
`PROTECTIVE ORDER MATERIAL
`
`Janssen Ex. 2051
`Lupin Ltd. v. Janssen Sciences Ireland UC
`IPR2015-01030
`(Page 12 of 74)
`
`

`
`Page 13
` Q. Do you know if he holds any other position
`within the Lupin family of companies?
` A. No.
` Q. You don't know or he does not?
` A. I don't think.
` Q. But you're not sure; is that correct?
`
` Q. Okay. Dr. Singh, if we can turn to
`paragraph 7, please.
` And I think you touched on this, but
`referring to, first, Ms. Rachita Naidu, who is her
`employer?
`
` Q. And who pays her salary?
`
` Q. And what is her role or title within Lupin
`Limited?
`
` Q. And you know Ms. Naidu personally; is that
`right?
` A. Yes.
` Q. And same question for Mr. Vishnupurikar,
`who is his employer?
`
`1
`2
`3
`4
`5
`6
`
`9
`10
`11
`12
`13
`
`15
`
`17
`18
`
`20
`21
`22
`23
`24
`
`212-267-6868
`
`Veritext Legal Solutions
`www.veritext.com
`
`516-608-2400
`
`PROTECTIVE ORDER MATERIAL
`
`Janssen Ex. 2051
`Lupin Ltd. v. Janssen Sciences Ireland UC
`IPR2015-01030
`(Page 13 of 74)
`
`

`
`Page 14
`
` Q. And what entity pays his salary?
`
` Q. And what is his role or title within Lupin
`Limited?
`
` Q. Okay. If we could focus, Dr. Singh, on
`the last sentence in paragraph 7, it starts "The
`individuals primarily responsible for the decision
`to file and the content of the instant petition are
`Rachita Naidu and Shirish Vishnupurikar"; do you
`see that?
` A. Which paragraph?
` Q. I'm sorry. Paragraph 7 on page 3. It's
`the last sentence.
` A. Yes.
` Q. Okay. When you say "primarily
`responsible," does that mean that there were other
`people involved in the preparation of the instant
`petition?
` MS. MAZZOCHI: Object to form.
` THE WITNESS: Only these two guys, they are
`responsible for preparing this.
`BY MR. MUNOZ:
` Q. So is that statement incorrect where it
`says "primarily responsible"?
`
`1
`
`3
`4
`
`6
`7
`8
`9
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`
`212-267-6868
`
`Veritext Legal Solutions
`www.veritext.com
`
`516-608-2400
`
`PROTECTIVE ORDER MATERIAL
`
`Janssen Ex. 2051
`Lupin Ltd. v. Janssen Sciences Ireland UC
`IPR2015-01030
`(Page 14 of 74)
`
`

`
`Page 15
`
` MS. MAZZOCHI: Object to form.
` THE WITNESS: I don't think so.
`BY MR. MUNOZ:
` Q. So you understand primarily responsible to
`mean that only Ms. Naidu and Mr. Vishnupurikar
`prepared this declaration, prepared the instant
`petition?
` MS. MAZZOCHI: Object to form.
`BY MR. MUNOZ:
` Q. Is that correct?
` MS. MAZZOCHI: Object to form.
` THE WITNESS: They two prepared with the
`consultation of our counsel in Chicago.
`BY MR. MUNOZ:
` Q. And were you, Dr. Singh, involved in the
`preparation of the instant petition?
` MS. MAZZOCHI: Object to form.
` THE WITNESS: No.
`BY MR. MUNOZ:
` Q. Dr. Singh, how do you know that no one
`else was involved in the preparation of the instant
`petition?
` MS. MAZZOCHI: Object to form.
` THE WITNESS: In my personal knowledge, I had
`number of discussions with Rachita Naidu and
`
`1
`2
`3
`4
`5
`6
`7
`8
`9
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`
`212-267-6868
`
`Veritext Legal Solutions
`www.veritext.com
`
`516-608-2400
`
`PROTECTIVE ORDER MATERIAL
`
`Janssen Ex. 2051
`Lupin Ltd. v. Janssen Sciences Ireland UC
`IPR2015-01030
`(Page 15 of 74)
`
`

`
`Page 16
`Shirish, and I was told that they are in touch with
`our counsel here in Chicago, and best of my
`knowledge, these are the two individuals who were
`involved preparing this in the case.
`BY MR. MUNOZ:
` Q. So is it fair to say that your belief that
`nobody else was involved in the preparation of the
`instant petition comes from information that was
`conveyed to you from Ms. Naidu and
`Mr. Vishnupurikar; is that correct?
` A. Yes.
` Q. Dr. Singh, are you familiar with the name
`Vinita Gupta?
` A. Yes.
` Q. And who is Ms. Gupta?
` A. She's CEO of Lupin Limited.
` Q. Does she hold any other positions within
`the Lupin family of companies?
` A. Yes. There are two entities in U.S.,
`Lupin, Inc., and Lupin Pharmaceuticals, Inc., and
`she's involved.
` Q. Do you know what her role is in those two
`companies?
` A. I have to see to produce me a document,
`like annual report, and I can tell you that.
`
`1
`2
`3
`4
`5
`6
`7
`8
`9
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`
`212-267-6868
`
`Veritext Legal Solutions
`www.veritext.com
`
`516-608-2400
`
`PROTECTIVE ORDER MATERIAL
`
`Janssen Ex. 2051
`Lupin Ltd. v. Janssen Sciences Ireland UC
`IPR2015-01030
`(Page 16 of 74)
`
`

`
`Page 17
`
`1
`2
`3
`4
`5
`6
`
` Q. Sure.
` But sitting right here you don't recall?
` A. Yes.
` Q. But you are sure she does hold positions
`at Lupin, Inc., and Lupin Pharma; is that correct?
` A. Yes.
`
`10
`11
`
` Q. How do you know that, Mr. Singh,
`Dr. Singh?
`
`17
`18
`19
`20
`21
`22
`23
`24
`
` Q. And you know that because Ms. Naidu and
`Mr. Vishnupurikar told you that; is that correct?
` A. Yes.
` Q. Dr. Singh, you also state in paragraph 7
`that Ms. Naidu is not employed by any Lupin
`subsidiaries; is that right?
` A. Yes.
` Q. And how do you know that, Dr. Singh?
`
`212-267-6868
`
`Veritext Legal Solutions
`www.veritext.com
`
`516-608-2400
`
`PROTECTIVE ORDER MATERIAL
`
`Janssen Ex. 2051
`Lupin Ltd. v. Janssen Sciences Ireland UC
`IPR2015-01030
`(Page 17 of 74)
`
`

`
`Page 18
`
`9
`
` Q. Okay.
`
`18
`19
`20
`21
`22
`23
`24
`25
`
` (Whereupon, Exhibit 2048 was
` marked for identification.)
`BY MR. MUNOZ:
` Q. Dr. Singh, I've handed you what has been
`marked as Exhibit 2048. Do you see that?
` A. Yes.
` Q. Do you recognize this document?
` A. Yes.
`
`212-267-6868
`
`Veritext Legal Solutions
`www.veritext.com
`
`516-608-2400
`
`PROTECTIVE ORDER MATERIAL
`
`Janssen Ex. 2051
`Lupin Ltd. v. Janssen Sciences Ireland UC
`IPR2015-01030
`(Page 18 of 74)
`
`

`
`1
`
`4
`5
`6
`7
`8
`
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`
` Q. What is it, Dr. Singh?
`
`Page 19
`
` Q. And what is the purpose of this document?
` MS. MAZZOCHI: Object to form.
`BY MR. MUNOZ:
` Q. And when I say "this document," I am
`referring to Exhibit 2048.
`
` Q. I see.
` Is it fair to say that you have seen this
`type of document outside the context of this
`proceeding?
` A. Yes.
` Q. Dr. Singh, if you look at the upper left
`corner, there is an acronym in there "LRP"; do you
`see that?
` A. Yes.
` Q. What does LRP stand for?
` A. Lupin Research Park.
` Q. And what is Lupin Research Park?
` A. Well, this is the research and development
`
`212-267-6868
`
`Veritext Legal Solutions
`www.veritext.com
`
`516-608-2400
`
`PROTECTIVE ORDER MATERIAL
`
`Janssen Ex. 2051
`Lupin Ltd. v. Janssen Sciences Ireland UC
`IPR2015-01030
`(Page 19 of 74)
`
`

`
`Page 20
`
`1
`2
`3
`4
`5
`6
`7
`8
`9
`10
`
`center.
` Q. Is it a building? A geographical
`location? Something else?
` A. Yes.
` Q. What is it?
` A. It's an area. It's about 19 acres of
`land, several buildings, which house a number of
`scientists.
` Q. Dr. Singh, if you look at the first
`sentence in Exhibit 2048,
`
`23
`
` Q. Sure. No problem.
`
`212-267-6868
`
`Veritext Legal Solutions
`www.veritext.com
`
`516-608-2400
`
`PROTECTIVE ORDER MATERIAL
`
`Janssen Ex. 2051
`Lupin Ltd. v. Janssen Sciences Ireland UC
`IPR2015-01030
`(Page 20 of 74)
`
`

`
`Page 21
`
`7
`
`9
`
`12
`
`14
`
`16
`
`21
`22
`23
`24
`25
`
` MS. MAZZOCHI: Object to form.
`
`BY MR. MUNOZ:
`
` MS. MAZZOCHI: Object to form.
`
`BY MR. MUNOZ:
`
` MS. MAZZOCHI: Object to form.
`
`BY MR. MUNOZ:
` Q. Any other companies?
` A. I don't remember. It could be many.
` Q. So the answer is, yes, but you don't
`remember?
`
`212-267-6868
`
`Veritext Legal Solutions
`www.veritext.com
`
`516-608-2400
`
`PROTECTIVE ORDER MATERIAL
`
`Janssen Ex. 2051
`Lupin Ltd. v. Janssen Sciences Ireland UC
`IPR2015-01030
`(Page 21 of 74)
`
`

`
`Page 22
`
`1
`2
`3
`4
`5
`6
`7
`
` MS. MAZZOCHI: Object to form.
`Mischaracterizes.
` MR. MUNOZ: I'm sorry. Let me rephrase that.
`BY MR. MUNOZ:
` Q. The answer is probably but you don't
`remember?
` MS. MAZZOCHI: Object to form.
`
`11
`
`BY MR. MUNOZ:
`
`20
`
` MS. MAZZOCHI: Object to form.
`
`25
`
`212-267-6868
`
`Veritext Legal Solutions
`www.veritext.com
`
`516-608-2400
`
`PROTECTIVE ORDER MATERIAL
`
`Janssen Ex. 2051
`Lupin Ltd. v. Janssen Sciences Ireland UC
`IPR2015-01030
`(Page 22 of 74)
`
`

`
`1
`2
`
`4
`
`6
`
`9
`
`11
`12
`13
`14
`
`17
`18
`19
`20
`21
`22
`23
`24
`25
`
`Page 23
`
`BY MR. MUNOZ:
` Q. Okay.
`
` MS. MAZZOCHI: Object to form.
`
`BY MR. MUNOZ:
`
` MS. MAZZOCHI: Object to form.
`
`BY MR. MUNOZ:
` Q. Are you saying that you're not sure?
` MS. MAZZOCHI: Object to form.
`Mischaracterizes.
`
`BY MR. MUNOZ:
` Q. Okay. If we go back to Exhibit 2048,
`Dr. Singh, there is a signature right above where
`it says "Authorized Signatory"; do you see that?
` A. Yes.
` Q. Whose signature is that?
` A. I can't identify.
` Q. Can you tell what the role of the person
`that signed this document is?
`
`212-267-6868
`
`Veritext Legal Solutions
`www.veritext.com
`
`516-608-2400
`
`PROTECTIVE ORDER MATERIAL
`
`Janssen Ex. 2051
`Lupin Ltd. v. Janssen Sciences Ireland UC
`IPR2015-01030
`(Page 23 of 74)
`
`

`
`Page 24
`
`6
`7
`8
`9
`10
`11
`12
`13
`14
`15
`
` Q. Okay. Dr. Singh, let me just, for the
`record, introduce what we are going to mark as
`Exhibit 2049.
` (Whereupon, Exhibit 2049 was
` marked for identification.)
`BY MR. MUNOZ:
` Q. And Dr. Singh, do you recognize
`Exhibit 2049?
` A. Yes.
` Q. And what is it?
`
`212-267-6868
`
`Veritext Legal Solutions
`www.veritext.com
`
`516-608-2400
`
`PROTECTIVE ORDER MATERIAL
`
`Janssen Ex. 2051
`Lupin Ltd. v. Janssen Sciences Ireland UC
`IPR2015-01030
`(Page 24 of 74)
`
`

`
`Page 25
`
`3
`
`5
`
`8
`
` MS. MAZZOCHI: Objection.
`
`BY MR. MUNOZ:
`
` MS. MAZZOCHI: Object to form.
`
`14
`
`BY MR. MUNOZ:
`
`19
`
` MS. MAZZOCHI: Object to form.
`
`22
`23
`
`BY MR. MUNOZ:
` Q. Okay.
`
`212-267-6868
`
`Veritext Legal Solutions
`www.veritext.com
`
`516-608-2400
`
`PROTECTIVE ORDER MATERIAL
`
`Janssen Ex. 2051
`Lupin Ltd. v. Janssen Sciences Ireland UC
`IPR2015-01030
`(Page 25 of 74)
`
`

`
`Page 26
`
`7
`
`9
`
`16
`17
`18
`19
`20
`21
`
` MS. MAZZOCHI: Form.
`
`BY MR. MUNOZ:
`
` MS. MAZZOCHI: I'll just caution you, in
`answering, you shouldn't reveal any attorney-client
`privilege information. You can speak generally.
` THE WITNESS: Can you repeat that, please.
`BY MR. MUNOZ:
` Q. Sure.
`
`24
`
` MS. MAZZOCHI: Same objections.
`
`212-267-6868
`
`Veritext Legal Solutions
`www.veritext.com
`
`516-608-2400
`
`PROTECTIVE ORDER MATERIAL
`
`Janssen Ex. 2051
`Lupin Ltd. v. Janssen Sciences Ireland UC
`IPR2015-01030
`(Page 26 of 74)
`
`

`
`Page 27
`
`5
`
`BY MR. MUNOZ:
`
`8
`9
`10
`
` MS. MAZZOCHI: I'll just caution you to answer
`that very generally so you are not revealing any
`privileged communications.
`
`15
`
`BY MR. MUNOZ:
`
`19
`
`21
`
`24
`25
`
` MS. MAZZOCHI: Object to form.
`
`BY MR. MUNOZ:
`
` MS. MAZZOCHI: Again, I'll just caution you not
`to reveal any substantive attorney-client
`
`212-267-6868
`
`Veritext Legal Solutions
`www.veritext.com
`
`516-608-2400
`
`PROTECTIVE ORDER MATERIAL
`
`Janssen Ex. 2051
`Lupin Ltd. v. Janssen Sciences Ireland UC
`IPR2015-01030
`(Page 27 of 74)
`
`

`
`privileged communications.
`
`Page 28
`
`BY MR. MUNOZ:
` Q. Okay. Dr. Singh, are you familiar with
`the name Sophia Mumtaz?
` A. Yes.
` Q. Who does she work for?
` MS. MAZZOCHI: Object to form.
`
`1
`
`4
`5
`6
`7
`8
`9
`
`12
`13
`
`BY MR. MUNOZ:
` Q. And how about today?
`
`17
`
` MS. MAZZOCHI: Object to form. Foundation.
`
`BY MR. MUNOZ:
`
` MS. MAZZOCHI: Object to form. Foundation.
` THE WITNESS:
`I don't know what entity.
`
`20
`
`22
`23
`24
`25
`
`212-267-6868
`
`Veritext Legal Solutions
`www.veritext.com
`
`516-608-2400
`
`PROTECTIVE ORDER MATERIAL
`
`Janssen Ex. 2051
`Lupin Ltd. v. Janssen Sciences Ireland UC
`IPR2015-01030
`(Page 28 of 74)
`
`

`
`Page 29
`
`BY MR. MUNOZ:
` Q. Is she the president of Lupin Limited?
` A. I have to check the annual report or
`business card. I don't remember.
`
` MS. MAZZOCHI: Object to form.
`
`1
`2
`3
`4
`
`7
`
`10
`
`BY MR. MUNOZ:
`
`16
`17
`18
`19
`
` MS. MAZZOCHI: Form.
` THE WITNESS: Sophia?
`BY MR. MUNOZ:
` Q. Yes.
`
`24
`
` MS. MAZZOCHI: Object to form.
`
`212-267-6868
`
`Veritext Legal Solutions
`www.veritext.com
`
`516-608-2400
`
`PROTECTIVE ORDER MATERIAL
`
`Janssen Ex. 2051
`Lupin Ltd. v. Janssen Sciences Ireland UC
`IPR2015-01030
`(Page 29 of 74)
`
`

`
`BY MR. MUNOZ:
`
`Page 30
`
` And correct the pronunciation if it's
`incorrect.
`
` Q. Do you know who she works for?
` A. I don't remember, but she's in the U.S.
` Q. But you don't know what Lupin entity she
`works for?
` A. I don't remember.
`
`1
`
`4
`5
`
`7
`8
`9
`10
`11
`
`18
`
` Q. I have to clarify the record.
`
`24
`25
`
` Q. Dr. Singh, you do know for the instant
`petition Lupin Pharma is listed as a real party in
`
`212-267-6868
`
`Veritext Legal Solutions
`www.veritext.com
`
`516-608-2400
`
`PROTECTIVE ORDER MATERIAL
`
`Janssen Ex. 2051
`Lupin Ltd. v. Janssen Sciences Ireland UC
`IPR2015-01030
`(Page 30 of 74)
`
`

`
`1
`2
`
`4
`
`7
`
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`
`Page 31
`
`interest, correct?
` A. Yes.
`
` MS. MAZZOCHI: Please answer that yes or no.
`
`BY MR. MUNOZ:
`
` Q. Dr. Singh, if we could go back to your
`declaration, Exhibit 1093, and if we could go to
`paragraph 10, please.
` You state, in the second sentence, that
`Lupin Inc., and Lupin Atlantis are holding
`companies; do you see that?
` A. Yes.
` Q. What do you mean by "holding companies"?
` A. Actually, these two companies are part of
`Lupin Limited, and I would say they are
`subsidiaries of Lupin Limited.
` Q. But what did you mean when you said they
`are "holding companies"?
` A. They are part -- they are arms of Lupin
`Limited, I would say, in layman's words.
` Q. I'm sorry. Repeat that.
`
`212-267-6868
`
`Veritext Legal Solutions
`www.veritext.com
`
`516-608-2400
`
`PROTECTIVE ORDER MATERIAL
`
`Janssen Ex. 2051
`Lupin Ltd. v. Janssen Sciences Ireland UC
`IPR2015-01030
`(Page 31 of 74)
`
`

`
`1
`
` A. Arms of Lupin Limited.
`
`Page 32
`
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`
` Q. Does Lupin Atlantis hold any patent
`rights?
` MS. MAZZOCHI: Object to form. Foundation.
` THE WITNESS: I don't know.
`BY MR. MUNOZ:
` Q. Do you know if Lupin Atlantis holds
`ownership of any patent applications?
` MS. MAZZOCHI: Object to form.
` THE WITNESS: I don't know.
`BY MR. MUNOZ:
`
`212-267-6868
`
`Veritext Legal Solutions
`www.veritext.com
`
`516-608-2400
`
`PROTECTIVE ORDER MATERIAL
`
`Janssen Ex. 2051
`Lupin Ltd. v. Janssen Sciences Ireland UC
`IPR2015-01030
`(Page 32 of 74)
`
`

`
`Page 33
`
`4
`5
`6
`7
`8
`9
`10
`
` Q. If we turn to paragraph 7, Dr. Singh, the
`next-to-last sentence of paragraph 7, on page 3,
`says "At no point was the filing content or funding
`of the instant petition discussed at any meeting of
`the board for any of the Lupin subsidiaries"; do
`you see that?
` A. Yes.
`
`23
`
` MS. MAZZOCHI: Object to the form.
`
`212-267-6868
`
`Veritext Legal Solutions
`www.veritext.com
`
`516-608-2400
`
`PROTECTIVE ORDER MATERIAL
`
`Janssen Ex. 2051
`Lupin Ltd. v. Janssen Sciences Ireland UC
`IPR2015-01030
`(Page 33 of 74)
`
`

`
`Page 34
`
`2
`
`5
`6
`
`BY MR. MUNOZ:
`
` MS. MAZZOCHI: Object to form.
` THE WITNESS:
`
`10
`
`BY MR. MUNOZ:
`
`16
`
` MS. MAZZOCHI: Form.
`
`21
`22
`23
`24
`25
`
`BY MR. MUNOZ:
` Q. Okay. Do you know who the members of the
`board of directors of Lupin Limited are?
` A. There could be many.
` Q. How many?
`
`212-267-6868
`
`Veritext Legal Solutions
`www.veritext.com
`
`516-608-2400
`
`PROTECTIVE ORDER MATERIAL
`
`Janssen Ex. 2051
`Lupin Ltd. v. Janssen Sciences Ireland UC
`IPR2015-01030
`(Page 34 of 74)
`
`

`
`Page 35
`
` A. I have to see the document.
` Q. Do you have an estimate?
` MS. MAZZOCHI: Object to form.
` THE WITNESS: Of my personal knowledge, I know
`Desh Bandhu Gupta, who is the chairman of Lupin
`Limited; Nilesh Gupta, who is managing director of
`Lupin Limited; Vinita Gupta, she's CEO of Lupin
`Limited, Dr. Karmal Sharma, who is the vice
`chairman of Lupin Limited. I remember these names.
`BY MR. MUNOZ:
` Q. Okay. Thank you.
`
` Q. Did you review meeting minutes from the
`board of Lupin Limited?
` A. No.
`
`1
`2
`3
`4
`5
`6
`7
`8
`9
`10
`11
`
`15
`16
`17
`
`21
`
` MS. MAZZOCHI: Object to form.
`
`212-267-6868
`
`Veritext Legal Solutions
`www.veritext.com
`
`516-608-2400
`
`PROTECTIVE ORDER MATERIAL
`
`Janssen Ex. 2051
`Lupin Ltd. v. Janssen Sciences Ireland UC
`IPR2015-01030
`(Page 35 of 74)
`
`

`
`Page 36
`
`5
`6
`7
`8
`9
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`
`BY MR. MUNOZ:
` Q. Dr. Singh, I asked you about the board
`members for Lupin Limited. Do you know who the
`board members are for Lupin Atlantis?
` A. I don't remember the names.
` Q. Do you know roughly how many board members
`there are at Lupin Atlantis?
` A. I can't guess.
` Q. Do you know any of the officers at Lupin
`Atlantis?
` A. I don't remember. If you show me a
`document, I'll recognize.
` Q. Sure.
` Do you know any of the officers of Lupin
`Atlantis?
` A. No.
` Q. Do you know who the board members of
`Lupin, Inc., are?
` A. I don't remember.
` Q. Do you know roughly how many board members
`Lupin, Inc., has?
`
`212-267-6868
`
`Veritext Legal Solutions
`www.veritext.com
`
`516-608-2400
`
`PROTECTIVE ORDER MATERIAL
`
`Janssen Ex. 2051
`Lupin Ltd. v. Janssen Sciences Ireland UC
`IPR2015-01030
`(Page 36 of 74)
`
`

`
`Page 37
`
` A. No.
` Q. Do you know who the officers of Lupin,
`Inc., are?
` A. No.
` Q. Do you know roughly how many officers
`Lupin, Inc., has?
` A. No.
` Q. Do you know the board of directors, the
`members of the board of directors of Lupin Pharma?
` A. No.
` Q. Do you know roughly how many board members
`Lupin Pharma has?
` A. No.
` Q. Do you know any of the officers of Lupin
`Pharma?
` MS. MAZZOCHI: Form.
` THE WITNESS: I don't remember.
`BY MR. MUNOZ:
` Q. Do you know roughly how many officers
`Lupin Pharma has?
` A. No.
` Q. Dr. Singh, who paid for the filing of the
`instant petition?
` A. Lupin Limited.
` Q. If we could turn to paragraph 7, the
`
`1
`2
`3
`4
`5
`6
`7
`8
`9
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`
`212-267-6868
`
`Veritext Legal Solutions
`www.veritext.com
`
`516-608-2400
`
`PROTECTIVE ORDER MATERIAL
`
`Janssen Ex. 2051
`Lupin Ltd. v. Janssen Sciences Ireland UC
`IPR2015-01030
`(Page 37 of 74)
`
`

`
`1
`2
`3
`4
`5
`6
`
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`
`Page 38
`bottom of page 2, you state that "Lupin Limited was
`also the sole party responsible for directing,
`controlling and funding the preparation and filing
`of the petition for inter partes review of the '987
`patent (the instant petition)"; do you see that?
` A. Yes.
`
` Q. If you turn to the next page, still on
`paragraph 7, you state that "No Lupin subsidiaries
`co-authored the instant petition"; do you see that?
` MS. MAZZOCHI: Object to form. I think you
`misread it.
` MR. MUNOZ: Let me read that to be clear.
`BY MR. MUNOZ:
` Q. I'll read the sentence so it's clear.
` "None of the Lupin subsidiaries
`participated in the decision to file the instant
`
`212-267-6868
`
`Veritext Legal Solutions
`www.veritext.com
`
`516-608-2400
`
`PROTECTIVE ORDER MATERIAL
`
`Janssen Ex. 2051
`Lupin Ltd. v. Janssen Sciences Ireland UC
`IPR2015-01030
`(Page 38 of 74)
`
`

`
`1
`2
`3
`4
`5
`6
`7
`8
`9
`10
`11
`12
`13
`14
`15
`16
`17
`18
`
`21
`22
`23
`24
`25
`
`Page 39
`
`petition nor did any co-author the instant
`petition"; do you see that?
` A. Yes.
` Q. What Lupin entity authored the instant
`petition?
` MS. MAZZOCHI: Object to form.
` THE WITNESS: I did not understand the
`question.
`BY MR. MUNOZ:
` Q. There is a statement in here from you that
`says that "No Lupin subsidiaries co-authored the
`instant petition"; is that right?
` MS. MAZZOCHI: Form.
` THE WITNESS: Yes.
`BY MR. MUNOZ:
` Q. And my question to you is which Lupin
`entity did author the petition?
` MS. MAZZOCHI: Object to form.
`
`BY MR. MUNOZ:
` Q. So when you say "authored," you're
`referring to expenses?
` MS. MAZZOCHI: Object to form.
`Mischaracterizes.
`
`212-267-6868
`
`Veritext Legal Solutions
`www.veritext.com
`
`516-608-2400
`
`PROTECTIVE ORDER MATERIAL
`
`Janssen Ex. 2051
`Lupin Ltd. v. Janssen Sciences Ireland UC
`IPR2015-01030
`(Page 39 of 74)
`
`

`
`1
`2
`3
`4
`5
`
`9
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`
`Page 40
` THE WITNESS: I'm not clear on that part.
`BY MR. MUNOZ:
` Q. You are not clear on this part in your
`declaration; is that correct?
` MS. MAZZOCHI: Objection. Mischaracterizes.
`
`BY MR. MUNOZ:
` Q. But the word that I'm trying to understand
`is "co-author." When you use the word "co-author,"
`were you referring to expenses?
` MS. MAZZOCHI: Object to form.
` THE WITNESS: No.
`BY MR. MUNOZ:
` Q. What were you referring to?
` A. No, I'm listing that no other subsidiary
`of Lupin has any controls on petition. It is only
`Lupin Limited.
` Q. So when you use the word "co-author," are
`you referring to control?
` MS. MAZZOCHI: Object to form.
` THE WITNESS: No.
`BY MR. MUNOZ:
` Q. What are you referring to, Dr. Singh, when
`
`212-267-6868
`
`Veritext Legal Solutions
`www.veritext.com
`
`516-608-2400
`
`PROTECTIVE ORDER MATERIAL
`
`Janssen Ex. 2051
`Lupin Ltd. v. Janssen Sciences Ireland UC
`IPR2015-01030
`(Page 40 of 74)
`
`

`
`Page 41
`
`1
`2
`3
`4
`5
`6
`7
`8
`9
`10
`11
`12
`13
`14
`15
`
`you use the word "co-author"?
` A. I don't know.
` Q. You don't know what the word "co-author"
`means in your declaration; is that correct?
` MS. MAZZOCHI:

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket